These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 23434396)

  • 1. Varicella immunity in vaccinated healthcare workers.
    Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
    J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.
    Bianchi FP; Tafuri S; Larocca AMV; Germinario CA; Stefanizzi P
    BMC Infect Dis; 2021 May; 21(1):475. PubMed ID: 34034659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
    Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
    Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers.
    Saiman L; LaRussa P; Steinberg SP; Zhou J; Baron K; Whittier S; Della-Latta P; Gershon AA
    Infect Control Hosp Epidemiol; 2001 May; 22(5):279-83. PubMed ID: 11428437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
    Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients.
    Prelog M; Schönlaub J; Jeller V; Almanzar G; Höfner K; Gruber S; Eiwegger T; Würzner R
    Vaccine; 2013 May; 31(20):2420-6. PubMed ID: 23583889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J; Schmid DS; Gershon AA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella-zoster virus-specific, cell-mediated immunity with interferon-gamma release assay after vaccination of college students with no or intermediate IgG antibody response.
    Terada K; Itoh Y; Fujii A; Kitagawa S; Ogita S; Ouchi K
    J Med Virol; 2015 Feb; 87(2):350-6. PubMed ID: 25080078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
    Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
    J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR; Witkop CT; Webber BJ; Costello AA
    Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.
    Kho MM; Zuijderwijk JM; van der Eijk AA; de Kuiper R; Boer-Verschragen MJ; Weimar W; van Besouw NM
    Vaccine; 2017 Jan; 35(1):71-76. PubMed ID: 27899225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection.
    Wu MF; Yang YW; Lin WY; Chang CY; Soon MS; Liu CE
    J Hosp Infect; 2012 Feb; 80(2):162-7. PubMed ID: 22188630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella-zoster virus immunity among health care workers in Catalonia.
    Urbiztondo L; Bayas JM; Broner S; Costa J; Esteve M; Campins M; Borrás E; Domínguez A;
    Vaccine; 2014 Oct; 32(45):5945-8. PubMed ID: 25219564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
    Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
    Berger R; Luescher D; Just M
    Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroconversion rates in healthcare workers using a latex agglutination assay after varicella virus vaccination.
    Weinstock DM; Rogers M; Lim S; Eagan J; Sepkowitz KA
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):504-7. PubMed ID: 10432164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.
    Jenke AC; Klein S; Baiker A; Wirth S; Sander M; Noelting C; Boecher O; Vizoso-Pinto MG
    Pediatr Infect Dis J; 2012 Nov; 31(11):1148-52. PubMed ID: 22863912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation.
    Sasadeusz J; Prince HM; Schwarer A; Szer J; Stork A; Bock HL; Povey M; Nicholson O; Innis BL
    Transpl Infect Dis; 2014 Dec; 16(6):1024-31. PubMed ID: 25272081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.